Explore Publications - CHÉOS: Centre for Health Evaluation & Outcome Sciences

Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review

Subst Abus Treat Prev PolicySeptember 11, 2019 Patient-Centred Care Substance Use & Addictions

Marchand K, Beaumont S, Westfall J, MacDonald S, Harrison S, Marsh DC, Schechter MT, Oviedo-Joekes E

Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: Growth mixture modeling using data from prospective cohort studies

AddictionJuly 22, 2019 Modelling & Risk Prediction Substance Use & Addictions

Dong H, Hayashi K, Singer J, Milloy M-J, Debeck K, Wood E, Kerr T

History of parenting instability and lifetime suicidal behavior in people who inject drugs

Psychiatry ResJuly 22, 2019 Mental Health & Wellbeing Public Health Social Determinants of Health Substance Use & Addictions

Tabi K, Choi F, Mithani Z, Nikoo M, Jang K, Krausz M

Electronic cigarette exposures reported to the British Columbia Drug and Poison Information Centre: An observational case series

CMAJ OpenJuly 18, 2019 Epidemiology Public Health Substance Use & Addictions

Choi A, Le M, Rahim T, Rose C, Kosatsky T

The time for emergency department opioid agonist therapy is now: “A BC perspective”

CJEMJuly 15, 2019 Editorial Emergency Medicine Substance Use & Addictions

Kestler A, Wale J, Allan M

Neonatal Abstinence Syndrome and Associated Neonatal and Maternal Mortality and Morbidity

PediatricsJuly 12, 2019 Paediatrics Reproductive & Maternal Health Substance Use & Addictions

Lisonkova S, Richter LL, Ting J, Muraca GM, Wen Q, Mehrabadi A, Mitchell-Foster S, Oviedo-Joekes E, Lyons J

Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs

Can Fam PhysicianMay 01, 2019 Drugs & Pharmaceuticals Primary Care Substance Use & Addictions

Crabtree A, Rose C, Chong M, Smolina K

Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods

J Subst AbuseApril 03, 2019 Cascade of Care Substance Use & Addictions

Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Harrison S, MacDonald S, Lock K, Anis AH, Marsh DC, Schechter MT

Rapid micro‐induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series

Am J AddictMarch 22, 2019 Substance Use & Addictions

Klaire S, Zivanovic R, Barbic SP, Sandhu R, Mathew N, Azar P

Yes, not now, or never: An analysis of reasons for refusing or accepting emergency department-based take-home naloxone

CJEMMarch 22, 2019 Emergency Medicine Substance Use & Addictions

Kestler A, Giesler A, Buxton J, Meckling G, Lee M, Hunte G, Wilkins J, Marks D, Scheuermeyer F

Filter by:

Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review

Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: Growth mixture modeling using data from prospective cohort studies

History of parenting instability and lifetime suicidal behavior in people who inject drugs

Electronic cigarette exposures reported to the British Columbia Drug and Poison Information Centre: An observational case series

The time for emergency department opioid agonist therapy is now: “A BC perspective”

Neonatal Abstinence Syndrome and Associated Neonatal and Maternal Mortality and Morbidity

Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs

Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods

Rapid micro‐induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series

Yes, not now, or never: An analysis of reasons for refusing or accepting emergency department-based take-home naloxone